Phase 3 randomized, open-label study to evaluate Eflornithine with Lomustine compared to Lomustine (STELLAR) alone in patients with Anaplastic Astrocytoma

Administered By

Awarded By

Contributors

Start/End

  • October 1, 2016 - July 15, 2022